Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2005
Associations between drug metabolism genotype, chemotherapy pharmacokinetics, and overall survival in patients with breast cancerWilliam P Petros, Penelope J Hopkins, Susan Spruill, et al.
Chemical Research in Toxicology|September 21, 2004
1,3- vs 1,5-intramolecular alkylation reactions in isophosphoramide and phosphoramide mustardsJames B Springer, Young H Chang, Kyo I Koo, et al.
Journal of Pain and Symptom Management|October 27, 2004
Prostate cancer in African Americans: relationship of patient and partner self-efficacy to quality of lifeLisa C Campbell, Francis J Keefe, Daphne C McKee, et al.
Molecular Cancer Therapeutics|August 3, 2007
Pharmacodynamic and pharmacokinetic study of chronic low-dose metronomic cyclophosphamide therapy in miceUrban Emmenegger, Yuval Shaked, Shan Man, et al.
Cancer Chemotherapy and Pharmacology|June 5, 2003
The activity of camptothecin analogues is enhanced in histocultures of human tumors and human tumor xenografts by modulation of extracellular pHJames L Flowers, Robert M Hoffman, Timothy A Driscoll, et al.
Molecular Cancer Therapeutics|September 16, 2004
Brain tumor cell lines resistant to O6-benzylguanine/1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy have O6-alkylguanine-DNA alkyltransferase mutationsManny D Bacolod, Stewart P Johnson, Anthony E Pegg, et al.
Magnetic Resonance in Medicine|October 10, 2006
Chemodosimetry of in vivo tumor liposomal drug concentration using MRIBenjamin L Viglianti, Ana M Ponce, Charles R Michelich, et al.
Neuro-Oncology|February 11, 2004
Review of microdialysis in brain tumors, from concept to application: first annual Carolyn Frye-Halloran symposiumRamsis K Benjamin, Fred H Hochberg, Elizabeth Fox, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Phase II trial of carmustine plus O(6)-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant gliomaJennifer A Quinn, James Pluda, M Eileen Dolan, et al.
Pageof 3